Of the total cases, 177 have been confirmed, and 20 patients are currently on ventilator support, says report.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

The deceased, a 59-year-old man resident of Khadakwasla, reportedly died while undergoing treatment at Kashibai Navale ...

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...

A 59-year-old man suffering from Guillain-Barre Syndrome (GBS) has died in a hospital here, taking the death toll due to the ...

GBS outbreak Pune: 59-year-old man suffering from Guillain-Barre Syndrome dies in Pune, death toll in city reaches eight.

Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

A teenage girl presented to the hospital emergency department with a three-week history of intermittent frontal headache, which was worse in the morning and associated with nausea, vomiting, lethargy, ...

As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more and more cases linking them ...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing a ...